78 related articles for article (PubMed ID: 1612550)
21. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
[TBL] [Abstract][Full Text] [Related]
22. Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria.
Suzuki S; Joh K
Clin Exp Nephrol; 2004 Jun; 8(2):109-16. PubMed ID: 15235927
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of olmesartan and temocapril on urinary liver-type fatty acid-binding protein levels in normotensive patients with immunoglobin A nephropathy.
Nakamura T; Inoue T; Sugaya T; Kawagoe Y; Suzuki T; Ueda Y; Koide H; Node K
Am J Hypertens; 2007 Nov; 20(11):1195-201. PubMed ID: 17954367
[TBL] [Abstract][Full Text] [Related]
24. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
26. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
Peters HP; van den Brand JA; Wetzels JF
Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
[TBL] [Abstract][Full Text] [Related]
27. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Kanno Y; Okada H; Saruta T; Suzuki H
Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus rescue therapy in resistant or relapsing cases of primary glomerulonephritis.
Arikan H; Koc M; Cakalagaoglu F; Eren Z; Segal MS; Tuglular S; Ozener C; Akoglu E
J Nephrol; 2008; 21(5):713-21. PubMed ID: 18949726
[TBL] [Abstract][Full Text] [Related]
29. [Primary IgA mesangial nephropathy (Berger's disease): clinico-pathological study].
Nussenzveig I; Saldanha LB; Marcondes M
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(1):7-20. PubMed ID: 2814190
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
[TBL] [Abstract][Full Text] [Related]
31. The impact of sex in primary glomerulonephritis.
Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
[TBL] [Abstract][Full Text] [Related]
32. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
[TBL] [Abstract][Full Text] [Related]
33. Dramatic response to corticosteroid therapy of nephrotic syndrome associated with IgA nephropathy.
Furuse A; Hiramatsu M; Adachi N; Karashima S; Hattori S; Matsuda I
Int J Pediatr Nephrol; 1985; 6(3):205-8. PubMed ID: 4055239
[TBL] [Abstract][Full Text] [Related]
34. Effects of eicosapentaenoic acid supplementation on immunoglobulin A nephropathy.
Uchiyama-Tanaka Y; Mori Y
Ther Apher Dial; 2010 Jun; 14(3):303-7. PubMed ID: 20609183
[TBL] [Abstract][Full Text] [Related]
35. [Study on a predictive marker for evaluating the effectiveness of steroid therapy in IgA nephropathy-significance of extracapillary changes].
Yamamoto S; Iesato K; Yoshida H; Hori J; Hasegawa R; Ohta Y; Akikusa B; Kondo Y
Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):74-83. PubMed ID: 8717309
[TBL] [Abstract][Full Text] [Related]
36. Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.
Ohya M; Otani H; Minami Y; Yamanaka S; Mima T; Negi S; Yukawa S; Shigematsu T
Clin Nephrol; 2013 Jul; 80(1):47-52. PubMed ID: 23557791
[TBL] [Abstract][Full Text] [Related]
37. Combined therapy in children and adolescents with IgA nephropathy.
Murakami K; Yoshioka K; Akano N; Takemura T; Okada M; Aya N; Hino S; Miyazato H; Yagi K; Maki S
Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
[TBL] [Abstract][Full Text] [Related]
38. [Effect of protease inhibitor on primary glomerulonephritis and the mechanism of the effect].
Onbe T; Makino H; Haramoto T; Wada J; Ogura T; Kumagai I; Murakami K; Fukushima M; Ota Z
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):753-9. PubMed ID: 1770635
[TBL] [Abstract][Full Text] [Related]
39. Effects of an anti-platelet drug (dilazep) in IgA nephropathy: comparison of clinical effects with renal biopsy findings.
Yoshida H; Kanatsu K; Muso E; Kuwahara T; Sekita K; Ono T; Konishi N; Kanda C; Minakata T; Morimoto K
Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):339-44. PubMed ID: 8022106
[TBL] [Abstract][Full Text] [Related]
40. [An IgA nephropathy case with highly reduced urinary protein concomitant with reduced obesity].
Nakamura T; Fujikura Y; Suga N; Hatazoe K; Hinoshita F
Nihon Jinzo Gakkai Shi; 2006; 48(7):675-9. PubMed ID: 17128885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
